0001562180-24-004340.txt : 20240523
0001562180-24-004340.hdr.sgml : 20240523
20240523160618
ACCESSION NUMBER: 0001562180-24-004340
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacoby Dana Lynn
CENTRAL INDEX KEY: 0001931319
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40128
FILM NUMBER: 24978183
MAIL ADDRESS:
STREET 1: C/O BIOTE CORP.
STREET 2: 1875 W. WALNUT HILL LN #100
CITY: IRVING
STATE: TX
ZIP: 75038
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: biote Corp.
CENTRAL INDEX KEY: 0001819253
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851791125
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1875 W. WALNUT HILL LN #100
CITY: IRVING
STATE: TX
ZIP: 75038
BUSINESS PHONE: 972-486-9346
MAIL ADDRESS:
STREET 1: 1875 W. WALNUT HILL LN #100
CITY: IRVING
STATE: TX
ZIP: 75038
FORMER COMPANY:
FORMER CONFORMED NAME: Haymaker Acquisition Corp. III
DATE OF NAME CHANGE: 20200727
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-05-21
false
0001819253
biote Corp.
BTMD
0001931319
Jacoby Dana Lynn
C/O BIOTE CORP.
1875 W. WALNUT HILL LN #100
IRVING
TX
75038
true
false
false
false
false
Class A Common Stock
2024-05-21
4
M
false
11595.00
A
50970.00
D
Deferred Settlement RSU
2024-05-21
4
M
false
11595.00
0.00
D
Class A Common Stock
11595.00
0.00
D
Deferred Settlement RSU
2024-05-21
4
A
false
12994.00
0.00
A
Class A Common Stock
12994.00
12994.00
D
Stock Option (Right to Buy)
5.57
2024-05-21
4
A
false
65258.00
0.00
A
2034-05-20
Class A Common Stock
65258.00
143763.00
D
Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2024 or the date of the Reporting Person's separation from service.
The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
All shares subject to the option award shall vest on the earlier of May 21, 2025 or the day prior to the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.
/s/ Marybeth Conlon, as Attorney-in-Fact for Dana L. Jacoby
2024-05-23